Sarepta

ORG Health Care / Biotechnology Momentum 12.8 NORMAL Primary: Spectral Shift

Sarepta Therapeutics is a biotechnology company specializing in gene therapy and precision genetic medicine, with a focus on rare neuromuscular diseases including Duchenne muscular dystrophy (DMD). The company develops and commercializes RNA-based therapeutics and gene therapy treatments.

0.00

PSI Score

12.8

Momentum

Confidence

Connections

Connected Entities

FDA Pfizer Roche

Watch This Entity

PSI Intelligence

30-Day Trend

Signal Decomposition

Attention Cascade

-0.316

Narrative Drift

0.000

Spectral Shift

445.166

Sentiment-Momentum Divergence

0.000

Source Concentration

1.000

Network Analysis

3 Degree Centrality

Centrality History

Entity	Weight	Status
FDA	4	NEW
Pfizer	4	NEW
Roche	1	NEW

Article Coverage (0)

Date	Lane	Title

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.